Search
for
Sort by
Research 30 of 523
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- 0935 Unravelling the role of JAK3/TEC kinase signalling with ritlecitinib in alopecia areata lesional skin and alopecia areata-induced human hair follicles ex vivo
- Kaempferol enhances hair growth by regulating JAK3/STAT6 and TGF-β/Smad signaling in human dermal papilla cells and a C57BL/6 mousemodel
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda minima
- Environmental Modulation of JAK3-Mediated Immune Dysregulation in Alopecia Areata
- 917 Frontal fibrosing alopecia scalp profiling links Th1/Th2 and JAK3 activation with fibrosis and loss of follicular stem cells
- <i>Lagerstroemia indica</i> extract regulates human hair dermal papilla cell growth and degeneration via modulation of β‐catenin, Stat6, and TGF‐β signaling pathway
- New drugs under investigation for the treatment of alopecias
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Cedrol in ginger (Zingiber officinale) as a promising hair growth drug: The effects of oral and external administration on hair regeneration and its mechanism
- 1322 Molecular profiling of frontal fibrosing alopecia (FFA) reveals TH1 and JAK-STAT up-regulation with no suppression of hair keratins
- The role of janus kinases in the treatment of autoimmune skin diseases
- Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- 455 Beyond Immunity: TEC and JAK3 Kinase Activation in Melanocytes Drives Inflammation in Vitiligo
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- CS12192 Reverses Alopecia Areata by Selectively Targeting JAK3/JAK1/TBK1.
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
- 046 Analysing the mechanistic basis of Ritlecitinib’s therapeutic effects in Alopecia Areata
- Langerin+ Dendritic Cells in Cutaneous Fibrosis: The TGF-β1 Signaling Axis
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- 1313 Fzd2 controls multiple aspects of epidermal development through distinct signaling mechanisms
- Hair Growth Stimulation Effect of Centipeda minima Extract: Identification of Active Compounds and Anagen-Activating Signaling Pathways
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- JAK inhibitors in dermatology: The promise of a new drug class
- Molecular Predictors of Ritlecitinib Efficacy in Alopecia Areata: Role of JAK3-Dependent Inflammation and Follicular Integrity
- 153 Effectiveness of OR-101, a next generation highly selective JAK3 inhibitor, in a humanized murine model of alopecia areata